• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

172.50 +1.86 (+1.09%)
Official Closing Price Updated: 4:15 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,570,281
Open 171.37
Bid (Size) 172.07 (400)
Ask (Size) 172.47 (200)
Prev. Close 170.64
Today's Range 170.80 - 175.02
52wk Range 107.43 - 179.64
Shares Outstanding N/A
Dividend Yield 0.21%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
February 10, 2026
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
February 09, 2026
The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration. 
Via Stocktwits

Performance

YTD
+2.1%
+2.1%
1 Month
+1.1%
+1.1%
3 Month
+4.4%
+4.4%
6 Month
+24.7%
+24.7%
1 Year
+26.3%
+26.3%

More News

Read More
News headline image
Why Is ALVO Stock Rising Pre-Market Today? ↗
February 05, 2026
Via Stocktwits
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via MarketMinute
Topics ETFs Government Initial Public Offering
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today ↗
January 16, 2026
Via Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval ↗
January 14, 2026
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
January 14, 2026
Via Stocktwits
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients ↗
January 13, 2026
Via Stocktwits
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
January 30, 2026
Via Stocktwits
News headline image
Why Did SER Stock Surge Over 70% In Pre-Market Today? ↗
January 29, 2026
Via Stocktwits
News headline image
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF ↗
January 27, 2026
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
January 24, 2026
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock ↗
December 29, 2025
Via Stocktwits
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It? ↗
January 20, 2026
Via Stocktwits
News headline image
Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet ↗
December 26, 2025
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? ↗
December 11, 2025
Via Stocktwits
Topics Artificial Intelligence Stocks
News headline image
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗
December 01, 2025
Via MarketBeat
News headline image
Clean Energy’s Second Wind: What iShares Global Clean Energy ETF Tells Us Now ↗
November 11, 2025
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals ↗
November 03, 2025
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
November 03, 2025
Via Benzinga
Topics ETFs
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
October 27, 2025
Via Benzinga
News headline image
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
October 15, 2025
Via Benzinga
News headline image
Enpro Moves To Boost Profits With $280 Million Acquisition Push ↗
October 13, 2025
Via Benzinga

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 172.50
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 02/13/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap